E-mail  
Home
 
AboutUs
 
Service
 
Products
 
Order Information
 
Contact us
Insert title here
Featured Products
HY-10005  |  Flavopiridol
HY-10008  |  SNS-032
HY-10012  |  AZD-5438
HY-10014  |  R547
HY-10032  |  PF 477736
HY-10087  |  Navitoclax
HY-10128  |  ZM-447439
HY-10161  |  Tozasertib
HY-10180  |  MLN8054
HY-10192  |  NVP-TAE 684
HY-10228  |  Motesanib
HY-10249  |  GSK-690693
HY-10355  |  AKT inhibitor VIII
HY-10358  |  MK 2206 (dihydrochloride)
HY-10992  |  AZD-7762
HY-10997  |  PCI-32765
HY-11001  |  PHA-793887
HY-11002  |  CP-466722
HY-11007  |  GNF-2
HY-11009  |  CGP60474
more    
Products
HY-100211

CAS:187034-31-7

187034-31-7  Technical Data: Price and Availability of  Cas No:187034-31-7

Cas : 187034-31-7 M.Wt: 415.5276
Cas : 187034-31-7 Formula: C19H37N5O5
Cas : 187034-31-7 Purity: >98 %
Cas : 187034-31-7 Storage: at 20℃ 2 years
Cas : 187034-31-7 Solubility: DMSO: ≥ 22 mg/mL
Cas : 187034-31-7 Name: TAPI-2
USD
1mg/$150 In-stock
5mg/$600 In-stock
10mg/$950 In-stock
1g Get quote
5g Get quote
>10g Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please
inquire via sales@chemexpress.cn
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
Online Inquiry
 
187034-31-7  Data Sheet:
 
Introduction of 187034-31-7 :
TAPI-2 is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC50 of 20±10 μM for MMP. IC50 & Target: IC50: 20±10 μM (MMP)[1] Ki: 1.5±0.27 nM (MMPs)[1] In Vitro: The hydroxamate-based metalloprotease inhibitor TAPI-2 bounds to hmeprin with inhibition constants IC50 20±10 μM for hmeprin β subunit and 1.5±0.27 nM for hmeprin α subunit. Generally, hmeprin α is inhibited more strongly than the β subunit[1]. Without affecting ADAM17 expression, TAPI-2 dramatically decreases the protein levels of NICD and its downstream target HES-1 in both HCP-1 and HT29 cells. Moreover, treating cells with TAPI-2 significantly decreases the CSC phenotype by -50% in both CRC cell lines. The dose-dependent effects of TAPI-2 on the sphere formation and protein levels of NICD and HES-1 confirm that the concentration used (20 μM) is within the effective dose range of TAPI-2 (5–40 μM)[2].
 
References on 187034-31-7 :
 

Keywords: buy TAPI-2 | TAPI-2 Supplier | purchase TAPI-2 | TAPI-2 cost | TAPI-2 manufacturer | order TAPI-2 | TAPI-2 distributor | TAPI-2 structure
buy 187034-31-7 | 187034-31-7 Supplier | purchase 187034-31-7 | 187034-31-7 cost | 187034-31-7 manufacturer | order 187034-31-7 | 187034-31-7 distributor | 187034-31-7 structure
Insert title here
 
Products are for research use only. Not for human use. We do not sell to patients.           Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China  
TEL:
86-21-58998590   FAX: 86-21-53700326, 86-21-58998590   E-mail: sales@chemexpress.cn